The procurement comprises radioactive isotopes for therapeutic and diagnostic use. The procurement is implemented on behalf of the four regional health authorities, Helse Nord, Helse Midt-Norge, Helse Vest and Helse Sør-Øst [the Northern Norway Regional Health Authority, Central Norway Regional Health Authority, Western Norway Regional Health Authority and the South Eastern Norway Regional Health Authority].